Insider Transactions in Q1 2021 at Atara Biotherapeutics, Inc. (ATRA)
Insider Transaction List (Q1 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 26
2021
|
Joe Newell Chief Operations Officer |
SELL
Open market or private sale
|
Direct |
2,640
-1.91%
|
$36,960
$14.58 P/Share
|
|
Mar 26
2021
|
Utpal Koppikar Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
1,761
-1.01%
|
$24,654
$14.58 P/Share
|
|
Mar 15
2021
|
Joe Newell Chief Operations Officer |
SELL
Open market or private sale
|
Direct |
7,000
-4.82%
|
$119,000
$17.41 P/Share
|
|
Mar 15
2021
|
Joe Newell Chief Operations Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,500
+2.35%
|
$42,000
$12.15 P/Share
|
|
Mar 02
2021
|
Pascal Touchon President and CEO |
SELL
Open market or private sale
|
Direct |
4,887
-1.31%
|
$78,192
$16.74 P/Share
|
|
Mar 02
2021
|
Utpal Koppikar Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
1,461
-0.83%
|
$23,376
$16.74 P/Share
|
|
Mar 02
2021
|
Joe Newell Chief Operations Officer |
SELL
Open market or private sale
|
Direct |
1,665
-1.16%
|
$26,640
$16.74 P/Share
|
|
Mar 01
2021
|
Pascal Touchon President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
117,187
+23.93%
|
-
|
|
Mar 01
2021
|
Utpal Koppikar Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
45,258
+20.47%
|
-
|
|
Mar 01
2021
|
Kristin Yarema Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
35,021
+27.51%
|
-
|
|
Mar 01
2021
|
Joe Newell Chief Operations Officer |
BUY
Grant, award, or other acquisition
|
Direct |
37,715
+20.83%
|
-
|
|
Mar 01
2021
|
Amar Murugan EVP, Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
41,756
+30.0%
|
-
|
|
Mar 01
2021
|
Jakob Dupont EVP, Head of R&D |
BUY
Grant, award, or other acquisition
|
Direct |
53,879
+34.98%
|
-
|
|
Feb 08
2021
|
Joe Newell Chief Operations Officer |
SELL
Open market or private sale
|
Direct |
3,886
-3.55%
|
$77,720
$20.39 P/Share
|
|
Feb 08
2021
|
Utpal Koppikar Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
1,759
-1.33%
|
$35,180
$20.39 P/Share
|
|
Jan 15
2021
|
Joe Newell Chief Operations Officer |
SELL
Open market or private sale
|
Direct |
7,000
-6.01%
|
$126,000
$18.84 P/Share
|
|
Jan 15
2021
|
Joe Newell Chief Operations Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,500
+2.92%
|
$42,000
$12.15 P/Share
|